Tannir NM - Search Results

1

Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma.

Motzer RJ, McDermott DF, Escudier B, Burotto M, Choueiri TK, Hammers HJ, Barthélémy P, Plimack ER, Porta C, George S, Powles T, Donskov F, Gurney H, Kollmannsberger CK, Grimm MO, Barrios C, Tomita Y, Castellano D, Grünwald V, Rini BI, McHenry MB, Lee CW, McCarthy J, Ejzykowicz F, Tannir NM. Motzer RJ, et al. Among authors: tannir nm. Cancer. 2022 Jun 1;128(11):2085-2097. doi: 10.1002/cncr.34180. Epub 2022 Apr 5. Cancer. 2022. PMID: 35383908 Free PMC article. Clinical Trial.

2

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes.

Rodney A, Dieringer P, Mathew P, Jonasch E, Tannir N, Pagliaro LC. Rodney A, et al. Cancer. 2006 May 15;106(10):2143-7. doi: 10.1002/cncr.21894. Cancer. 2006. PMID: 16598751 Free article. Clinical Trial.

3

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.

Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Tannir N, et al. Cancer. 2006 Aug 1;107(3):497-505. doi: 10.1002/cncr.22038. Cancer. 2006. PMID: 16795067 Free article. Clinical Trial.

4

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Among authors: tannir nm. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

5

Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.

Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Spiess PE, et al. Among authors: tannir nm. Cancer. 2006 Oct 1;107(7):1483-90. doi: 10.1002/cncr.22182. Cancer. 2006. PMID: 16944541 Free article.

6

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinoma.

Tannir NM, Cohen L, Wang X, Thall P, Mathew PF, Jonasch E, Siefker-Radtke A, Pagliaro LC, Ng CS, Logothetis C. Tannir NM, et al. Cancer. 2006 Nov 1;107(9):2254-61. doi: 10.1002/cncr.22253. Cancer. 2006. PMID: 17029276 Free article. Clinical Trial.

7

Treatment outcomes of small cell carcinoma of the prostate: a single-center study.

Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE, Do KA, Davuluri R, Tannir NM. Spiess PE, et al. Among authors: tannir nm. Cancer. 2007 Oct 15;110(8):1729-37. doi: 10.1002/cncr.22971. Cancer. 2007. PMID: 17786954 Free article. Clinical Trial.

8

Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases.

Mathew P, Thall PF, Bucana CD, Oh WK, Morris MJ, Jones DM, Johnson MM, Wen S, Pagliaro LC, Tannir NM, Tu SM, Meluch AA, Smith L, Cohen L, Kim SJ, Troncoso P, Fidler IJ, Logothetis CJ. Mathew P, et al. Among authors: tannir nm. Clin Cancer Res. 2007 Oct 1;13(19):5816-24. doi: 10.1158/1078-0432.CCR-07-1269. Clin Cancer Res. 2007. PMID: 17908974 Clinical Trial.

9

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?

Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Spiess PE, et al. Among authors: tannir nm. Cancer. 2007 Dec 15;110(12):2700-8. doi: 10.1002/cncr.23104. Cancer. 2007. PMID: 17948916 Free article.

10

Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma.

Ebbinghaus S, Hussain M, Tannir N, Gordon M, Desai AA, Knight RA, Humerickhouse RA, Qian J, Gordon GB, Figlin R. Ebbinghaus S, et al. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6689-95. doi: 10.1158/1078-0432.CCR-07-1477. Clin Cancer Res. 2007. PMID: 18006769 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page